Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Goodwill (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Goodwill for 15 consecutive years, with $144.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill changed N/A to $144.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $144.3 million, a N/A change, with the full-year FY2024 number at $144.2 million, up 742.99% from a year prior.
  • Goodwill was $144.3 million for Q3 2025 at Usana Health Sciences, up from -$110000.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $144.3 million in Q3 2025 to a low of -$110000.0 in Q2 2025.
  • A 5-year average of $35.5 million and a median of $17.4 million in 2021 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: soared 2796.74% in 2023, then crashed 100.65% in 2025.
  • Usana Health Sciences' Goodwill stood at $17.5 million in 2021, then decreased by 0.81% to $17.4 million in 2022, then decreased by 1.53% to $17.1 million in 2023, then soared by 742.99% to $144.2 million in 2024, then increased by 0.08% to $144.3 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Goodwill are $144.3 million (Q3 2025), -$110000.0 (Q2 2025), and $144.2 million (Q1 2025).